Stockscreener 앱 받기
6.20
58.57%
2.29
시장 영업 전:
5.90
-0.30
-4.84%
Dbv Technologies Adr 주식(DBVT)의 최신 뉴스
DBV Technologies (NASDAQ:DBVT) Coverage Initiated by Analysts at StockNews.com - Defense World
European ADRs See Mixed Results With Biopharma Leading Gains - Finimize
Why DBV Technologies (DBVT) Stock Is Skyrocketing - Benzinga
European Equities Traded in the US as American Depositary Receipts Lower in Friday Trading - TradingView
US Stocks Likely To Open Lower, Analysts Warn 'Prolonged Uncertainty Could Hurt Both US And Global Risk Assets' - Benzinga
DBV Technologies announces up to $307M financing to advance Viaskin Peanut program - MSN
DBV Technologies Announces Financing of up to $306.9 - GlobeNewswire
Major Breakthrough: $306.9M Funding Powers Revolutionary Peanut Allergy Patch to FDA Finish Line - StockTitan
European Equities Traded in the US as American Depositary Receipts Rise in Tuesday Trading - TradingView
DBV Technologies (NASDAQ:DBVT) vs. Jasper Therapeutics (NASDAQ:JSPR) Head to Head Comparison - Defense World
European Equities Traded in the US as American Depositary Receipts Higher in Monday Trading - TradingView
DBV Technologies faces cash shortage, stock drops By Investing.com - Investing.com South Africa
DBV Technologies faces cash shortage, stock drops - Investing.com
DBV Technologies Secures Agreement with FDA on Safety - GlobeNewswire
Major FDA Breakthrough: DBV's Peanut Allergy Treatment Path Accelerates Despite Cash Concerns - StockTitan
DBV Technologies (NASDAQ:DBVT) Coverage Initiated at StockNews.com - Defense World
European Equities Traded in the US as American Depositary Receipts Track Lower in Wednesday Trading - TradingView
European Equities Traded in the US as American Depositary Receipts Edge Lower in Tuesday Trading - TradingView
European Equities Traded in the US as American Depositary Receipts Track Higher in Monday Trading - TradingView
European Equities Traded in the US as American Depositary Receipts Decline in Tuesday Trading - MSN
European Equities Traded in the US as American Depositary Receipts Rise in Friday Trading, Down for Week - TradingView
DBV Technologies’ SWOT analysis: peanut allergy patch stock faces crucial trials By Investing.com - Investing.com South Africa
DBV Technologies’ SWOT analysis: peanut allergy patch stock faces crucial trials - Investing.com
European Equities Traded in the US as American Depositary Receipts Fall in Monday Trading - MSN
European Equities Traded in the US as American Depositary Receipts Lower Wednesday - TradingView
European Equities Traded in the US as ADRs Fall in Tuesday Trading - TradingView
JMP reiterates DBV Technologies stock with $10 target - Investing.com
European Equities Traded in the US as American Depositary Receipts Surge Higher in Monday Trading - TradingView
DBV Technologies (DBVT) Projected to Post Quarterly Earnings on Thursday - MarketBeat
European Equities Traded in the US as American Depositary Receipts Rise in Friday Trading, Remain Flat for Week - TradingView
DBV Technologies (DBVT) to Release Earnings on Thursday - Defense World
DBV Technologies to Participate in Upcoming AAAAI/WAO Joint Congress - The Manila Times
DBV Technologies (NASDAQ:DBVT) Earns Hold Rating from Analysts at StockNews.com - Defense World
Can This Peanut Patch Help Children Safely Eat 3-4 Peanuts? New 5-Year Data Reveals Promising Results - StockTitan
Bank Stocks Lead European Equities Traded in the US as American Depositary Receipts Higher in Tuesday Trading - TradingView
DBV Technologies’ SWOT analysis: peanut allergy patch stock faces funding hurdles - Investing.com India
DBV Technologies' SWOT analysis: peanut allergy patch stock faces funding hurdles - Investing.com UK
European Equities Traded in the US as American Depositary Receipts Rise in Monday Trading - TradingView
DBV Technologies (NASDAQ:DBVT) vs. Allogene Therapeutics (NASDAQ:ALLO) Critical Contrast - Defense World
European Equities Traded in the US as American Depositary Receipts Edge Lower in Wednesday Trading - MSN
DBV Technologies (NASDAQ:DBVT) Now Covered by StockNews.com - MarketBeat
DBV Technologies (NASDAQ:DBVT) Stock Crosses Above 50-Day Moving AverageTime to Sell? - MarketBeat
European Equities Traded in the US as American Depositary Receipts Lower in Wednesday Trading - TradingView
DBV Technologies stock holds firm with $10 target from JMP By Investing.com - Investing.com South Africa
DBV Technologies stock holds firm with $10 target from JMP - Investing.com India
DBV Technologies (NASDAQ:DBVT) Shares Cross Above Fifty Day Moving Average – Time to Sell? - Defense World
1.91%
0.39%
자본화:
|
볼륨(24시간):